Cited by 151Smoking Behavior and CessationSubstance Abuse Treatment and OutcomesPrenatal Substance Exposure Effects

Psychiatric disorders in smokers seeking treatment for tobacco dependence: Relations with tobacco dependence and cessation.

Open access
Piper, Megan E., Smith, Stevens S., Schlam, Tanya R., Fleming, Michael F., Bittrich, Amy A., Brown, Jennifer L., Leitzke, Cathlyn J., Zehner, Mark E. +2 more·2010·Journal of Consulting and Clinical Psychology

Abstract

OBJECTIVE: The present research examined the relation of psychiatric disorders to tobacco dependence and cessation outcomes. METHOD: Data were collected from 1,504 smokers (58.2% women; 83.9% White; mean age = 44.67 years, SD = 11.08) making an aided smoking cessation attempt as part of a clinical trial. Psychiatric diagnoses were determined with the Composite International Diagnostic Interview structured clinical interview. Tobacco dependence was assessed with the Fagerström Test of Nicotine Dependence (FTND) and the Wisconsin Inventory of Smoking Dependence Motives (WISDM). RESULTS: Diagnostic groups included those who were never diagnosed, those who had ever been diagnosed (at any time, including in the past year), and those with past-year diagnoses (with or without prior diagnosis). Some diagnostic groups had lower follow-up abstinence rates than did the never diagnosed group (ps < .05). At 8 weeks after quitting, strong associations were found between cessation outcome and both past-year mood disorder and ever diagnosed anxiety disorder. At 6 months after quitting, those ever diagnosed with an anxiety disorder (OR = .72, p = .02) and those ever diagnosed with more than one psychiatric diagnosis (OR = .74, p = .03) had lower abstinence rates. The diagnostic categories did not differ in smoking heaviness or the FTND, but they did differ in dependence motives assessed with the WISDM. CONCLUSION: Information on recent or lifetime psychiatric disorders may help clinicians gauge relapse risk and may suggest dependence motives that are particularly relevant to affected patients. These findings also illustrate the importance of using multidimensional tobacco dependence assessments.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1037/a0018065

Cites

82 of 82 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Covey LS 2000 Tobacco cessation among patients with depression Primary Care 26 691 706 10436294

Cited by

Sorted by citations

Authors
Piper, M. E., Smith, S. S., Schlam, T. R., Fleming, M. F., Bittrich, A. A., Brown, J. L., Leitzke, C. J., Zehner, M. E., Fiore, M. C., & Baker, T. B.
Affiliations
University of Wisconsin–Madison (US)
Venue
Journal of Consulting and Clinical Psychology
Published
2010-02
Volume
78
Issue
1
Pages
13-23
ISSN
  • 0022-006X (ISSN-L)
  • 1939-2117
OpenAlex
W2094429523
Cited by
150
References
79
Citations by year
2025: 1 · 2024: 8 · 2023: 9 · 2022: 4 · 2021: 4 · 2020: 8 · 2019: 7 · 2018: 10 · 2017: 8 · 2016: 14 · 2015: 16 · 2014: 16 · 2013: 10 · 2012: 19
FWCI
9.53
Type
journal article
Language
en
Open access
Locations
  • Journal of Consulting and Clinical Psychology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (P50 DA019706, M01 RR03186)
  • University of Wisconsin—Madison (1KL2RR025012-01)
  • National Cancer Institute (1K05CA139871)
  • GlaxoSmithKline
  • Elan Corporation, plc.
Topics
  • Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
Keywords
mental illness, tobacco dependence, smoking cessation, mood disorders, anxiety disorders, abstinence rates, relapse risk, smoking heaviness
MeSH terms
Adult, Anxiety Disorders, Double-Blind Method, Female, Humans, Male, Middle Aged, Motivation, Nicotine, Psychiatric Status Rating Scales, Surveys and Questionnaires, Regression Analysis, Smoking, Tobacco Use Disorder, Smoking Cessation, Treatment Outcome, Patient Selection, Mood Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review